NIH-funded research R01 grant

Understanding how bacteria adapt to survive antibiotic treatment

Official title: Rapid Stress Response in Bacterial Pathogens: the Role of Extant Porins in Antibiotic Tolerance

Funded at Texas Engineering Experiment Station · NIH-11168200 · Data updated 2026-11-12

This study looks at how certain harmful bacteria can become resistant to antibiotics by changing their outer layer, focusing on special proteins that help antibiotics get inside the bacteria, with the goal of finding new ways to fight infections that don't respond to treatment.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startMay 28, 2025
Project endApril 30, 2030
Funding year2025
Award (this year)$637,275
NIH project number1R01AI188941-01A1
Project IDNIH-11168200 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant Gram-negative bacteria.

Less likely to help

Patients with infections caused by non-Gram-negative bacteria or those not affected by antibiotic resistance may not benefit from this research.

What this research studies

This research investigates how Gram-negative bacterial pathogens develop tolerance to antibiotics through rapid changes in their outer membrane. It focuses on the role of porins, which are proteins that control the entry of antibiotics into bacterial cells. By studying how these bacteria can quickly inhibit the function of existing porins when exposed to antibiotics, the research aims to uncover new mechanisms of antibiotic resistance. This could lead to better strategies for combating antibiotic-resistant infections.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively overcome antibiotic resistance in bacterial infections.

How similar studies have gone: Other research has shown promising results in understanding bacterial resistance mechanisms, but this specific approach focusing on extant porins is relatively novel.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Lele, Pushkar Prakash — Texas Engineering Experiment Station
  • Study coordinator: Lele, Pushkar Prakash

Related research

Other NIH-funded projects on the same topics.

  • Robotic dental implants to deliver stem cells

    A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11591543

  • Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis

    A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11577865

  • Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk

    This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11456681

  • Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones

    A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11449053

  • Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer

    Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448647

  • Targeted nanoparticle therapy for lung fibrosis

    A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448075

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.